8-K
filed December 11, 2023, 6:59 PM ET
ticker DRIO
CIK 0001533998
other material
confidence high
sentiment neutral
materiality 0.15
DarioHealth annual meeting results: directors elected, say-on-pay approved, frequency set to 3 years
DarioHealth Corp.
- All seven director nominees elected with majority support; Hila Karah received 10,656,884 votes for.
- Ratification of Ernst & Young as auditor passed with 17,523,243 votes for, 497,398 against.
- Issuance of dividend shares to Series B-2 preferred holders approved (12,283,574 for, 230,691 against).
- Advisory vote on named executive officer compensation passed with 8,934,199 for (75% of votes cast).
- Stockholders selected three years as frequency for future say-on-pay votes (5,949,982 votes for 3 years).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
DarioHealth Corp. shareholders approved Advisory Vote on the Compensation of the Company's Named Executive Officers at the 2023-12-11 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-12-11
Exact text from the filing
The stockholders approved the compensation of the Company's named executive officers.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
DarioHealth Corp. shareholders approved Election of Directors at the 2023-12-11 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-12-11
Exact text from the filing
The stockholders elected the following directors of the Company to hold office until the next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
DarioHealth Corp. shareholders approved Issuance of Dividend Shares to Holders of Series B-2 Convertible Preferred Stock at the 2023-12-11 meeting.
- Outcome
- passed
- Meeting
- 2023-12-11
Exact text from the filing
The stockholders approved the issuance of certain dividend shares to executives and officers of the Company that hold Series B-2 Convertible Preferred Stock.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
DarioHealth Corp. shareholders approved Frequency of Advisory Vote on the Compensation of the Company's Named Executive Officers at the 2023-12-11 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-12-11
Exact text from the filing
The stockholders approved three (3) years as the frequency to hold a non-binding, advisory vote relating to the compensation of the Company's named executive officers. The votes were as follows: One Year Two Years Three Years Abstain Broker Non-Votes 5,770,310 116,872 5,949,982 689,529 5,555,024
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
DarioHealth Corp. shareholders approved Ratification of Auditors at the 2023-12-11 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-11
Exact text from the filing
The stockholders ratified the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.